Amedisys Inc AMED

$100.99 +0.01 (0.01%)

Valuation

Market cap
3,321,258,000
Revenue TTM
$2,348,320,000
Net income TTM
$43,230,000
P/E (trailing)
21.26
P/E (forward)
19.86
Profit margin
1.84%
Debt to equity
0.28

Trading

Volume
1,060,000
Avg volume
571,922
Day's range
$100.93 – $101.02
Shares out
32,887,000
Stochastic %K
99%
Beta
0.89
Analysts
Hold
Price target
$100.83

Price

Company profile

Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation thera...

Show more

Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc.

Industry
Medical Care Facilities
Sector
Healthcare
Phone
225 292 2031
Website
https://www.amedisys.com
Address
3854 American Way, Suite A, Baton Rouge, United States

Latest news

Stocktwits

MikiTrader Aug 28, 2:33 PM
$AMED My guess is the exact same players behind WHLR are doing the pumping here. Why ask? I just have a feeling. They are just regulating the speed. It's about to dive off a cliff with a massive red candle out of nowhere. But they'll probably pump it up every once in a while because doing it that way means they can't maximize their profits.
0 replies
AlloyKore_BBliever Sep 29, 6:48 PM
$ACHC $ALGN $AMED $BAX $BMRN If prices closes at this price today it will invalidates the red candle
1 replies
AlloyKore_BBliever Sep 29, 6:48 PM
$ACHC $ALGN $AMED $BAX $BMRN any close above 54.18 for Biomarin invalidates the big red 🕯️
0 replies
AlloyKore_BBliever Sep 29, 6:32 PM
$ACHC $ALGN $AMED $BAX $BMRN Biomarin holding the VWAP from earnings.
0 replies
AlloyKore_BBliever Sep 29, 6:31 PM
$ACHC $ALGN $AMED $BAX $BMRN Bought. Let's rip.
0 replies
topstockalerts Sep 8, 2:02 PM
UnitedHealth Group shares rose after the company reaffirmed its 2025 earnings guidance during investor meetings scheduled for Sept. 8–10. The SEC filing notes that executives plan to maintain the previously shared adjusted EPS expectations from July 29, 2022. The guidance accounts for the August 2025 Amedisys acquisition, which is expected to be “moderately dilutive” to adjusted EPS due to financing and integration costs. Investor meetings may also cover strategy, market positions, and previously disclosed results. The market reacted positively, reflecting confidence in UnitedHealth’s ability to maintain earnings forecasts despite short-term financial impact from the acquisition. $UNH $AMED
0 replies
JesterOfWallSt Aug 21, 11:57 AM
$MAGH 👈👀🃏 $NIKI $AMED $ISPC
1 replies
ISHARETRADEALERTS Aug 20, 11:03 PM
$AMED added 1.57 after canceled offering
0 replies